Security record · archived quarter
URGN
UroGen Pharma Ltd. · Healthcare · Biotechnology
13Tracked holders
0Δ holders
4.33MShares held
$47.90MReported value
+0New positions
−0Exits
Momentum inputs (comparable managers): holder breadth 0.0% · share flow -30.0% · net new positions 0.0% — formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q1 2025
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 76 | +11 | 16.33M | $599.97M | +14 | −3 |
| Q1 2026 | 68 | -2 | 16.64M | $299.41M | +7 | −9 |
| Q4 2025 | 71 | 0 | 16.74M | $392.08M | — | — |
| Q3 2025 | 18 | -2 | 12.72M | $253.85M | — | −2 |
| Q2 2025 | 17 | +1 | 7.27M | $99.60M | +1 | — |
| Q1 2025 | 13 | 0 | 4.33M | $47.90M | — | — |
| Q4 2024 | 13 | +2 | 6.43M | $68.46M | +2 | — |
| Q3 2024 | 10 | -2 | 7.92M | $100.53M | — | −2 |
| Q2 2024 | 12 | — | 7.91M | $132.72M | — | — |
Who holds it · Q1 2025
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Adage Capital Partners ✦ | 1.28M | -56.4% | $14.12M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 2 | State Street Global Advisors ✦ (passive) | 795.01K | -1.6% | $8.79M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passive) | 473.33K | +2.5% | $5.24M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passive) | 473.33K | +2.5% | $5.24M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | Millennium Management ✦ | 423.58K | -34.4% | $4.68M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 6 | T. Rowe Price ✦ | 368.65K | -6.4% | $4.08M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 7 | T. Rowe Price ✦ | 368.65K | -6.4% | $4.08M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 8 | Point72 Asset Management ✦ | 236.01K | -25.6% | $2.61M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 9 | Citadel Advisors ✦ | 189.68K | -17.1% | $2.10M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 10 | ARK Investment Management ✦ | 185.79K | +32.6% | $2.05M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 11 | Wellington Management ✦ | 148.08K | +0.8% | $1.64M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 12 | Wellington Management ✦ | 148.08K | +0.8% | $1.64M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 114.07K | +347.5% | $1.26M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 114.07K | +347.5% | $1.26M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 114.07K | +347.5% | $1.26M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 114.07K | +347.5% | $1.26M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 114.07K | +347.5% | $1.26M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 18 | Renaissance Technologies ✦ | 90.60K | -34.4% | $1.00M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | Two Sigma Investments ✦ | 17.29K | -69.6% | $191,205 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 20 | Marshall Wace ✦ | 11.50K | -91.6% | $127,190 | 0.0% | ▼ Trim | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 171 holders, 46.40M shares, $801.72M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q1 2025 ·
Methodology ·
Get this via the API